Global HIV Vaccine Enterprise donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Wikipedia pagehttps://en.wikipedia.org/wiki/Global_HIV_Vaccine_Enterprise

Donation amounts by donor and year for donee Global HIV Vaccine Enterprise

Donor Total 2017 2016 2013 2012 2007 2006
Bill and Melinda Gates Foundation (filter this donee) 22,902,815.00 749,999.00 749,216.00 500,000.00 -3,500,000.00 20,000,000.00 4,403,600.00
Total 22,902,815.00 749,999.00 749,216.00 500,000.00 -3,500,000.00 20,000,000.00 4,403,600.00

Full list of donations in reverse chronological order (6 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation749,999.002017-10-17Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation749,216.002016-02-10Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation500,000.002013-06-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to convene researchers, advocates, clinicians, policy makers, private sector partners and public health experts in South Africa to share and discuss the latest research in ARV-based prevention, vaccines and related areas of HIV prevention; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-3,500,000.002012-08-02Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide an operational support grant to the Global HIV Vaccine Enterprise. Operational Support to the Enterprise Secretariat. Investment start date: 10/1/2007 to end date: 12/31/2017. Grantee name: Global HIV Vaccine Enterprise; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation20,000,000.002007-10-09Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide an operational support grant to the Global HIV Vaccine Enterprise. Operational Support to the Enterprise Secretariat. Investment start date: 10/1/2007 to end date: 12/31/2017. Grantee name: Global HIV Vaccine Enterprise; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,403,600.002006-06-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- for general operating support. Operational support grant-Enterprise Secretariat. Investment start date: 6/1/2006 to end date: 6/1/2007. Grantee name: Global HIV Vaccine Enterprise; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.